MALAT1 and myocardial infarction: MALAT1, like MIAT1, shows a pro-fibrotic effect in the heart, and its knockdown via lentivirus-delivered MALAT1 siRNA is able to ameliorate the observed MI-impaired cardiac function, infarct size and ECM deposition in vivo.